AzTrials
AzTrials

Fracture of PatellaNCT01509729

Topical Lidocaine After Major Arthroscopic Knee Surgery

A study testing Knee arthroscopic surgery in people with Fracture of Patella and Pain, run by Northern Orthopaedic Division, Denmark at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pain after major arthroscopic surgery is dependent on an optimal multimodal analgesic treatment. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Fracture of Patella, Pain
What is being tested?
Knee arthroscopic surgery
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
21 participants
Where
1 siteDenmark
Study dates
Jun 2011to Jan 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who were planned for reconstruction of anterior crucial ligament, reconstruction of medial patellofemoral ligament and Elmslie-Trillat procedure for patella instability.
  • Patients with synovectomies and menisci resection lasting more than 25 minutes.
  • Patients > 18 years
  • Acceptance of informed consent

Who cannot join

  • Patients with rheumatoid arthritis
  • Patients with a Body Mass index of > 35
  • Patients who can not read and understand Danish
  • Fertile women who does not use secure contraception

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Orthopaedic Surgery Research Unit, Aarhus University, Aalborg Hospital

    Aalborg, 9000

Other trials in Denmark

About this study

Official title: Topical Lidocaine Patch Does Not Have an Analgesic Effect After Major Arthroscopic Knee Surgery. A Double-blind Place-controlled Randomized Study

Pain after major arthroscopic surgery is dependent on an optimal multimodal analgesic treatment.

Read the detailed description

Lidocaine is well-known as analgesic treatment on skin and hypodermic veins. Since 1996 it has been documented that topical lidocaine has an analgesic effect 24 hours after surgical treatment.

The aim is to determine a possible reduction in pain after knee arthroscopy with topical lidocaine.

Being tested
Sham operation, Knee arthroscopic surgery
Keywords
Knee, Arthroscopy, Lidocaine patch, Pain management after knee arthroscopy
Medical subject headings
Patella Fracture, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sham operationProcedure or surgery

    Also called Knee soft-tissue

    A randomized group of patients received a placebo patch. As a supplement, each patient was given a dose of morphine, as required.

  • Knee arthroscopic surgeryProcedure or surgery

    Also called Knee soft-tissue

    A randomized group of patients was given small patches with active 5% lidocaine.

Study groups in NCT01509729
Study groupRoleWhat they receive
Sham operationPlacebo comparatorNot described
Receives: Procedure: Sham operation
Knee arthroscopic surgeryActive comparatorNot described
Receives: Procedure: Knee arthroscopic surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Administration of analgesic drugs

    Time for the first necessary administration of analgesic drugs.

    Measured: 24 hours

Secondary outcomes (1)
  1. Pain management after surgical treatment

    The intake of necessary analgesic drugs after 6, 12, 18 and 24 hours after surgical treatment.

    Pain score according to the VAS scale when the patients rest and make movements.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2012 (estimated)
  2. Study startJun 2011
  3. Primary completionJan 2012
  4. Study completionJan 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01509729
Sponsor's protocol ID
N-20110028
Status last verified
Apr 2015
First submitted
29 Nov 2011
Last updated
10 Apr 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Knee arthroscopic surgery in people with Fracture of Patella and Pain, run by Northern Orthopaedic Division, Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Administration of analgesic drugs (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in